Cvikota Medical Business Services

CMS Takes Steps to Ensure Medicare Beneficiaries Have Wide Access to COVID-19 Antibody Treatment

CMS LogoThe Centers for Medicare & Medicaid Services announced that starting today, Medicare beneficiaries can receive coverage of monoclonal antibodies to treat coronavirus disease 2019 (COVID-19) with no cost-sharing during the public health emergency (PHE). CMS’ coverage of monoclonal antibody infusions applies to bamlanivimab, which received an emergency use authorization (EUA) from the U.S. Food and Drug Administration yesterday.

"Today, CMS is announcing a historic, first-of-its kind policy that drastically expands access to COVID-19 monoclonal antibodies to beneficiaries without cost sharing," said CMS Administrator Seema Verma. "Our timely approach means beneficiaries can receive these potentially life-saving therapies in a range of settings – such as in a doctor’s office, nursing home, infusion centers, as long as safety precautions can be met. This aggressive action and innovative approach will undoubtedly save lives."

Read more >>

Please Share Me On

Cvikota Medical Business Services is also affiliated with Cvikota EMS Ambulance Billing Professionals, as well as our website development division, Webteam, Inc. Cvikota MBS serves clients nation-wide, with offices in Wisconsin and Tennessee.


Cvikota Medical Business Services
2031 32nd Street South
La Crosse, Wisconsin, 54601 USA
608-788-8103
800-657-5175 · fx: 608-788-6613
contact@cvikotambs.com
www.cvikotambs.com
Privacy Policy


  Website Design by Webteam, Inc